|
1
|
Kleihues P, Louis DN, Scheithauer BW,
Rorke LB, Reifenberger G, Burger PC and Cavenee WK: The WHO
classification of tumours of the nervous system. J Neuropathol Exp
Neurol. 61:215–225. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Legler JM, Ries LA, Smith MA, Warren JL,
Heineman EF, Kaplan RS and Linet MS: Cancer surveillance series
(corrected): Brain and other central nervous system cancers: Recent
trends in incidence and mortality. J Natl Cancer Inst.
91:1382–1390. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kramm C, Rausche U, Butenhoff S, Kühnöl C,
Kunze C, Kortmann R, Wolff J and van Gool S: Hochmaligne Gliome im
Kindes-und Jugendalter. Monatschr Kinderheilkd. 156:1201–1207.
2008. View Article : Google Scholar
|
|
6
|
Stupp R and Weber DC: The role of radio-
and chemotherapy in glioblastoma. Onkologie. 28:315–317.
2005.PubMed/NCBI
|
|
7
|
Ohgaki H and Kleihues P: Population-based
studies on incidence, survival rates and genetic alterations in
astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol.
64:479–489. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Larjavaara S, Mäntylä R, Salminen T,
Haapasalo H, Raitanen J, Jääskeläinen J and Auvinen A: Incidence of
gliomas by anatomic location. Neuro Oncol. 9:319–325. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smith MT, Ludwig CL, Godfrey AD and
Armbrustmacher VW: Grading of oligodendrogliomas. Cancer.
52:2107–2114. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bailey P and Cushing H: Microchemical
color reactions as an Aid to the Identification and classification
of brain tumours. Proc Natl Acad Sci USA. 11:82–84. 1925.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Collins VP: Gene amplification in human
gliomas. Glia. 15:289–296. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dirks PB and Rutka JT: Current concepts in
neuro-oncology: The cell cycle - a review. Neurosurgery.
40:1000–1015. 1997. View Article : Google Scholar
|
|
13
|
Ohgaki H, Dessen P, Jourde B, Horstmann S,
Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM,
Maiorka PC, et al: Genetic pathways to glioblastoma: A
population-based study. Cancer Res. 64:6892–6899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmidt MC, Antweiler S, Urban N, Mueller
W, Kuklik A, Meyer-Puttlitz B, Wiestler OD, Louis DN, Fimmers R and
von Deimling A: Impact of genotype and morphology on the prognosis
of glioblastoma. J Neuropathol Exp Neurol. 61:321–328. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nozaki M, Tada M, Kobayashi H, Zhang CL,
Sawamura Y, Abe H, Ishii N and Van Meir EG: Roles of the functional
loss of p53 and other genes in astrocytoma tumorigenesis and
progression. Neuro Oncol. 1:124–137. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rao JS: Molecular mechanisms of glioma
invasiveness: The role of proteases. Nat Rev Cancer. 3:489–501.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maria BL, Eskin TA and Quisling RG:
Brainstem and other malignant gliomas: II. Possible mechanisms of
brain infiltration by tumour cells. J Child Neurol. 8:292–305.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelial-mesenchymal transition in cancer: Parallels between
normal development and tumour progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Townsend TA, Wrana JL, Davis GE and
Barnett JV: Transforming growth factor-beta-stimulated endocardial
cell transformation is dependent on Par6c regulation of RhoA. J
Biol Chem. 283:13834–13841. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Greenburg G and Hay ED: Epithelia
suspended in collagen gels can lose polarity and express
characteristics of migrating mesenchymal cells. J Cell Biol.
95:333–339. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumour metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Savanger P: Leaving the neighbourhood:
Molecular mechanisms involved during epithelial-mesenchymal
transition. Bioessays. 23:912–923. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mendez MG, Kojima S and Goldman RD:
Vimentin induces changes in cell shape, motility and adhesion
during the epithelial to mesenchymal transition. FASEB J.
24:1838–1851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Boyer B, Vallès AM and Edme N: Induction
and regulation of epithelial-mesenchymal transition. Biochem
Pharmacol. 60:1091–1099. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chaffer CL, Thompson EW and Williams ED:
Mesenchymal to epithelial transition in development and disease.
Cells Tissues Organs. 185:7–19. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ozdamar B, Bose R, Barrios-Rodiles M, Wang
HR, Zhang Y and Wrana JL: Regulation of the polarity protein Par6
by TGFbeta receptors controls epithelial cell plasticity. Science.
307:1603–1609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ikenouchi J, Matsuda M, Furuse M and
Tsukita S: Regulation of tight junctions during the
epithelium-mesenchyme transition: Direct repression of the gene
expression of claudins/occludin by Snail. J Cell Sci.
116:1959–1967. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumour
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Savagner P, Yamada KM and Thiery JP: The
zinc-finger protein slug causes desmosome dissociation, an initial
and necessary step for growth factor-induced epithelial-mesenchymal
transition. J Cell Biol. 137:1403–1419. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumour metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim K, Lu Z and Hay ED: Direct evidence
for a role of beta-catenin/LEF-1 signaling pathway in induction of
EMT. Cell Biol Int. 26:463–476. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Logullo AF, Nonogaki S, Pasini FS, Osório
CA, Soares FA and Brentani MM: Concomitant expression of
epithelial-mesenchymal transition biomarkers in breast ductal
carcinoma: Association with progression. Oncol Rep. 23:313–320.
2010.PubMed/NCBI
|
|
35
|
Mikheeva SA, Mikheev AM, Petit A, Beyer R,
Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H,
González-Herrero I, et al: TWIST1 promotes invasion through
mesenchymal change in human glioblastoma. Mol Cancer. 9:1942010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu QC, Gao RY, Wu W and Qin HL:
Epithelial-mesenchymal transition and its role in the pathogenesis
of colorectal cancer. Asian Pac J Cancer Prev. 14:2689–2698. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Han SP, Kim JH, Han ME, Sim HE, Kim KS,
Yoon S, Baek SY, Kim BS and Oh SO: SNAI1 is involved in the
proliferation and migration of glioblastoma cells. Cell Mol
Neurobiol. 31:489–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
Barrallo-Gimeno A and Nieto MA: The Snail
genes as inducers of cell movement and survival: implications in
development and cancer. Development. 132:3151–3161. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Paznekas WA, Okajima K, Schertzer M, Wood
S and Jabs EW: Genomic organization, expression and chromosome
location of the human SNAIL gene (SNAI1) and a related processed
pseudogene (SNAI1P). Genomics. 62:42–49. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Inukai T, Inoue A, Kurosawa H, Goi K,
Shinjyo T, Ozawa K, Mao M, Inaba T and Look AT: SLUG, a
ces-1-related zinc finger transcription factor gene with
antiapoptotic activity, is a downstream target of the E2A-HLF
oncoprotein. Mol Cell. 4:343–352. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Rosanò L, Cianfrocca R, Spinella F, Di
Castro V, Nicotra MR, Lucidi A, Ferrandina G, Natali PG and Bagnato
A: Acquisition of chemoresistance and EMT phenotype is linked with
activation of the endothelin A receptor pathway in ovarian
carcinoma cells. Clin Cancer Res. 17:2350–2360. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thiery JP and Sleeman JP: Complex networks
orchestrate epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 7:131–142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Beckman G, Beckman L, Pontén J and
Westermark B: G-6-PD and PGM phenotypes of 16 continuous human
tumor cell lines. Evidence against cross-contamination and
contamination by HeLa cells. Hum Hered. 21:238–241. 1971.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Stein GH: T98G: An anchorage-independent
human tumor cell line that exhibits stationary phase G1 arrest in
vitro. J Cell Physiol. 99:43–54. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Diserens AC, de Tribolet N, Martin-Achard
A, Gaide AC, Schnegg JF and Carrel S: Characterization of an
established human malignant glioma cell line: LN-18. Acta
Neuropathol. 53:21–28. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pontén J and Macintyre EH: Long term
culture of normal and neoplastic human glia. Acta Pathol Microbiol
Scand. 74:465–486. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Neumann I, Foell JL, Bremer M, Volkmer I,
Korholz D, Burdach S and Staege MS: Retinoic acid enhances
sensitivity of neuroblastoma cells for imatinib mesylate. Pediatr
Blood Cancer. 55:464–470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Casas E, Kim J, Bendesky A, Ohno-Machado
L, Wolfe CJ and Yang J: Snail2 is an essential mediator of
Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 71:245–254. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li Y, Wang W, Wang W, Yang R, Wang T, Su
T, Weng D, Tao T, Li W, Ma D, et al: Correlation of TWIST2
up-regulation and epithelial-mesenchymal transition during
tumorigenesis and progression of cervical carcinoma. Gynecol Oncol.
124:112–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang
Z, Yang CJ, Yuan L and Ouyang G: Twist2 contributes to breast
cancer progression by promoting an epithelial-mesenchymal
transition and cancer stem-like cell self-renewal. Oncogene.
30:4707–4720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Elias MC, Tozer KR, Silber JR, Mikheeva S,
Deng M, Morrison RS, Manning TC, Silbergeld DL, Glackin CA, Reh TA,
et al: TWIST is expressed in human gliomas and promotes invasion.
Neoplasia. 7:824–837. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Maier HJ, Schmidt-Strassburger U, Huber
MA, Wiedemann EM, Beug H and Wirth T: NF-kappaB promotes
epithelial-mesenchymal transition, migration and invasion of
pancreatic carcinoma cells. Cancer Lett. 295:214–228. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Luo GQ, Li JH, Wen JF, Zhou YH, Hu YB and
Zhou JH: Effect and mechanism of the Twist gene on invasion and
metastasis of gastric carcinoma cells. World J Gastroenterol.
14:2487–2493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wick W, Weller M, Weiler M, Batchelor T,
Yung AW and Platten M: Pathway inhibition: Emerging molecular
targets for treating glioblastoma. Neuro Oncol. 13:566–579. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Niclou SP, Fack F and Rajcevic U: Glioma
proteomics: Status and perspectives. J Proteomics. 73:1823–1838.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Frosina G: Development of therapeutics for
high grade gliomas using orthotopic rodent models. Curr Med Chem.
20:3272–3299. 2013. View Article : Google Scholar : PubMed/NCBI
|
